BRAF and melanoma: The distribution of the molecular subtypes among the described major etiopathogenic groups was the following: the “BRAF+” subtype was significantly associated with the nevogenic melanomas (39/75, 52.0% vs. 9/31, 29.0%), while “NF1+” was related to the CSD melanomas (1/37, 1.3% vs. 9/31, 29.0%) (p < 0.001) (Table 3).